A cyclin-dependent kinase-mediated phosphorylation switch of disordered protein condensation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A cyclin-dependent kinase-mediated phosphorylation switch of disordered protein condensation ; volume:14 ; number:1 ; day:9 ; month:10 ; year:2023 ; pages:1-23 ; date:12.2023
Nature Communications ; 14, Heft 1 (9.10.2023), 1-23, 12.2023
- Urheber
-
Valverde, Juan Manuel
Dubra, Geronimo
Phillips, Michael
Haider, Austin
Elena-Real, Carlos
Fournet, Aurélie
Alghoul, Emile
Chahar, Dhanvantri
Andrés-Sanchez, Nuria
Paloni, Matteo
Bernadó, Pau
Mierlo, Guido van
Vermeulen, Michiel
Toorn, Henk van den
Heck, Albert J. R.
Constantinou, Angelos
Barducci, Alessandro
Ghosh, Kingshuk
Sibille, Nathalie
Knipscheer, Puck
Krasinska, Liliana
Fisher, Daniel
Altelaar, Maarten
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-42049-0
- URN
-
urn:nbn:de:101:1-2024020510225090729545
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Valverde, Juan Manuel
- Dubra, Geronimo
- Phillips, Michael
- Haider, Austin
- Elena-Real, Carlos
- Fournet, Aurélie
- Alghoul, Emile
- Chahar, Dhanvantri
- Andrés-Sanchez, Nuria
- Paloni, Matteo
- Bernadó, Pau
- Mierlo, Guido van
- Vermeulen, Michiel
- Toorn, Henk van den
- Heck, Albert J. R.
- Constantinou, Angelos
- Barducci, Alessandro
- Ghosh, Kingshuk
- Sibille, Nathalie
- Knipscheer, Puck
- Krasinska, Liliana
- Fisher, Daniel
- Altelaar, Maarten
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension